SCHEMBL2540282

SCHEMBL2540282

COc1ccc(C2CCC(C=O)CC2)c(F)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.35
PDE5A O76074 2/20 0.35
HTR2C P28335 2/20 0.33
PIN1 Q13526 1/20 0.32
ERN1 O75460 1/20 0.32
MRGPRX4 Q96LA9 1/20 0.32
ADRA1A P35348 2/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
TYK2 P29597 1/20 0.32
JAK3 P52333 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
HCRTR2 O43614 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HTR1A P08908 1/20 0.30
SLC6A2 P23975 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2540281 1.00 USP30 (0.35) USP30PDE5AHTR2CPIN1ERN1
SCHEMBL12994249 0.87 HTR2C (0.41) USP30PDE5AHTR2CADRA1AALOX5AP
SCHEMBL425810 0.85 KDM1A (0.34) JAK2JAK1TYK2JAK3HCRTR2
SCHEMBL1574664 0.85 KDM1A (0.34) JAK2JAK1TYK2JAK3HCRTR2
SCHEMBL4549748 0.85 ALDH1A1 (0.35) USP30PDE5AHTR2CADRA1AALOX5AP
SCHEMBL12716293 0.85 ALDH1A1 (0.35) USP30PDE5AHTR2CADRA1AALOX5AP
SCHEMBL803246 0.84 HTR2C (0.33) USP30PDE5AHTR2CADRA1AALOX5AP
SCHEMBL4549750 0.84 HTR2C (0.33) USP30PDE5AHTR2CADRA1AALOX5AP
SCHEMBL13389438 0.82 ALOX5AP (0.33) USP30PDE5AHTR2CADRA1AALOX5AP
SCHEMBL11894578 0.82 KDM1A (0.32) JAK2JAK1TYK2JAK3HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8398887-B2 Liquid crystal compounds of butylenes YANTAI VALIANT FINE CHEMICALS CO., LTD. (CN) 2013-03-19 US disclosed
US-20110260106-A1 LIQUID CRYSTAL COMPOUNDS OF BUTYLENES VALIANT CORPORATION LIMITED (CN) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110260106-A1 LIQUID CRYSTAL COMPOUNDS OF BUTYLENES OR10J3, CNOT1, MYB USP30 3563/4885PDE5A 4364/4885HTR2C 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.